13 June 2026 in Journal of Arrhythmology
This review summarizes the anatomical and physiological characteristics of the sinoatrial node as a model for bio pacemakers and analyzes current approaches to their development, including sinoatrial node cell transplantation, the use of pluripotent stem cells, gene therapy (HCN overexpression, IK1 suppression, TBX18 transduction, and others), as well as combined and reprogramming strategies Special attention is given to the authors’ own experience and achievements in tissue engineering. Key obstacles to clinical translation are outlined, including safety concerns, stability of therapeutic effects, adequacy of experimental models, and control of biological pacemaker activity. Despite existing limitations, pro gress in gene engineering, stem cell technologies, and biomaterials offers promising opportunities for the development of fully physiological alternatives to electronic pacemakers.